Retatrutide is a next-generation injectable peptide designed to target multiple metabolic pathways for powerful effects on weight loss, insulin sensitivity, and overall body composition. As a triple agonist of GLP-1, GIP, and glucagon receptors, Retatrutide offers a synergistic approach to appetite control, energy balance, and fat oxidation—making it one of the most promising compounds in advanced metabolic therapy.
Retatrutide activates three key receptors:
GLP-1: Enhances insulin secretion, slows gastric emptying, and reduces appetite
GIP: Improves insulin sensitivity and supports fat metabolism
Glucagon: Promotes energy expenditure and lipolysis
This multi-receptor targeting leads to:
Accelerated fat loss
Improved glycemic control
Enhanced metabolic flexibility
Rapid Weight Reduction: Supports significant fat loss while preserving lean mass
Appetite Suppression: Reduces hunger and improves satiety
Blood Sugar Regulation: Enhances insulin response and glucose stability
Cardiometabolic Health: May improve lipid profiles and reduce inflammation
⚠️ Usage Note:
This product is intended for research purposes.